Evidence map›Paper›PMID 41609063›Full record

ArticleHaematologica2026

Myelodysplastic syndrome with cryptic 5q deletions in young male patients showing sustained response to lenalidomide.

Wala Najar, Lauren Barette, Dominique Penther, Odile Maarek, Aspasia Stamatoullas, Juliette Penichoux, Elena-Liana Veresezan, Sylvie Daliphard, Gerard Buchonnet, Victor Bobee and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wala NajarCentre Henri Becquerel, Department of Hematology, Rouen.
Lauren BaretteService hematologie seniors, Hopital Saint-Louis, Assistance Publique-Hopitaux de Paris and Universite Paris Cite.
Dominique PentherCentre Henri Becquerel, Department of Genetic Oncology, Rouen.
Odile MaarekLaboratoire d'hematologie, Hopital Saint-Louis, Assistance Publique-Hopitaux de Paris, and Universite Paris Cite.
Aspasia StamatoullasCentre Henri Becquerel, Department of Hematology, Rouen.
Juliette PenichouxCentre Henri Becquerel, Department of Hematology, Rouen.
Elena-Liana VeresezanCentre Henri Becquerel, Department of Pathology, Rouen.
Sylvie DaliphardCharles Nicolle University Hospital, Department of Biological Hematology, Rouen.
Gerard BuchonnetCharles Nicolle University Hospital, Department of Biological Hematology, Rouen.
Victor BobeeCharles Nicolle University Hospital, Department of Biological Hematology, Rouen.
Fabrice JardinCentre Henri Becquerel, Department of Hematology, Rouen, France; Inserm U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen.
Stephane De BottonGustave Roussy Cancer Campus, Department of Hematology, Villejuif.
Pierre FenauxService hematologie seniors, Hopital Saint-Louis, Assistance Publique-Hopitaux de Paris and Universite Paris Cite.
Vincent CamusCentre Henri Becquerel, Department of Hematology, Rouen, France; Inserm U1245, Cancer and Brain Genomics, Centre Henri Becquerel, University of Rouen, Rouen. vincent.camus@chb.unicancer.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41609063
PMCPMC13317843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.